. "Amoxicilline"@en . "alpha-amino-P-Hydroxybenzylpenicillin"@en . . "Amoxicillin anhydrous"@en . . . . . . . . . . " Chlamydia psittaci"@en . "26787-78-0"@en . . . . . . . . . . . . . . . . . . . . . "Moxal"@en . . " "@en . "Amoxicillin"@en . . "Amoxycillin"@en . . . "6-(P-Hydroxy-alpha-aminophenylacetamido)penicillanic acid"@en . "p-Hydroxyampicillin"@en . . "61.3 minutes"@en . . "(2S,5R,6R)-6-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid"@en . . . . . . . . . . . . . . . . . . . . . . "Most of the amoxicillin is excreted unchanged in the urine; its excretion can be delayed by concurrent administration of probenecid."@en . . . "Amoxicilina"@en . . . . . . . . . . . . . . . " "@en . . "Chlamydia pneumoniae"@en . . . . "Gram negative and gram positive bacteria"@en . "Borrelia burgdorferi"@en . . . . . . . . . . . . . . . . . . . . . "Amopenixin"@en . "For the treatment of infections of the ear, nose, and throat, the genitourinary tract, the skin and skin structure, and the lower respiratory tract due to susceptible (only b-lactamase-negative) strains of Streptococcus spp. (a- and b-hemolytic strains only), S. pneumoniae, Staphylococcus spp., H. influenzae, E. coli, P. mirabilis, or E. faecalis. Also for the treatment of acute, uncomplicated gonorrhea (ano-genital and urethral infections) due to N. gonorrhoeae (males and females)."@en . . . "Serious toxicity is unlikely following large doses of amoxicillin. Acute ingestion of large doses of amoxicillin may cause nausea, vomiting, diarrhea and abdominal pain. Acute oliguric renal failure and hematuria may occur following large doses."@en . . "AX"@en . . . . . . . . "6-(p-hydroxy-\u03B1-aminophenylacetamido)penicillanic acid"@en . . . . . . . . . . . . "Enteric bacteria and other eubacteria"@en . . . . . . . . . . . . . . . . "Amoxicillinum"@en . "A broad-spectrum semisynthetic antibiotic similar to ampicillin except that its resistance to gastric acid permits higher serum levels with oral administration. Amoxicillin is commonly prescribed with clauvanic acid (a beta lactamase inhibitor) as it is susceptible to beta-lacatamase degradation. [PubChem]"@en . . . "approved"@en . . . . . "Amoxicillin binds to penicillin-binding protein 1A (PBP-1A) located inside the bacterial cell well. Penicillins acylate the penicillin-sensitive transpeptidase C-terminal domain by opening the lactam ring. This inactivation of the enzyme prevents the formation of a cross-link of two linear peptidoglycan strands, inhibiting the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that amoxicllin interferes with an autolysin inhibitor."@en . . . . "# Drawz SM, Bonomo RA: Three decades of beta-lactamase inhibitors. Clin Microbiol Rev. 2010 Jan;23(1):160-201. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/20065329"@en . . . . . . . . "Streptococcus pyogenes"@en . "Amoxicillin"@en . . "Take without regard to meals."@en . . . . "Clamoxyl"@en . "\u03B1-amino-p-hydroxybenzylpenicillin"@en . . . . . "Salmonella typhi"@en . . . "Amox"@en . . . . "Streptococcus pneumoniae"@en . . . . . . . . "Amolin"@en . . . . "Joan Cabre, Jose Diago, Asuncion Esteve, Johannes Ludescher, \"Production of a crystalline salt of amoxicillin.\" U.S. Patent US6103897, issued April, 1971."@en . . . . . . . . . . . . . . . . "Rapidly absorbed after oral administration."@en . . "In blood serum, amoxicillin is approximately 20% protein-bound"@en . . "AMPC"@en . . .